GO:0042163 interleukin-12 beta subunit binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042163 (interleukin-12 beta subunit binding) is a molecular function defined as binding to the beta subunit of interleukin-12 (IL-12), also known as IL-12p40.
• The IL-12 beta subunit (p40) is a shared component of IL-12 and IL-23, and its binding is critical for receptor assembly and signaling.
• The functional IL-12 receptor complex comprises two beta-type cytokine receptor subunits, IL-12Rβ1 and IL-12Rβ2, which bind IL-12p40 and IL-12p35 respectively.
• IL-12p40 homodimers act as potent antagonists of IL-12 by competing for receptor binding.
• IL-12 signaling involves Jak2 tyrosine kinase association with the IL-12Rβ2 subunit, leading to STAT4 activation.
• Dysregulation of IL-12 beta subunit binding is implicated in autoimmune diseases, chronic inflammation, and cancer [2,3].
Description
Interleukin-12 (IL-12) is a heterodimeric cytokine composed of a p35 alpha subunit and a p40 beta subunit, and it plays a central role in the induction of cell-mediated immunity. The molecular function GO:0042163, interleukin-12 beta subunit binding, refers to the binding to the beta subunit of IL-12 (p40). This function is essential for the assembly of the IL-12 receptor complex and the initiation of downstream signaling events. Understanding this binding event is crucial for researchers studying immune regulation, inflammatory diseases, and cancer immunology [2,3].
interleukin-12 beta subunit binding At A Glance
| GO ID | GO:0042163 |
|---|---|
| GO term | interleukin-12 beta subunit binding |
| Ontology | molecular_function |
| Synonym | CLMFp40 binding, IL-12B binding, IL-12p40 binding, NKSFp40 binding |
| Major function | Binding to the beta subunit (p40) of interleukin-12, facilitating receptor assembly and signaling |
| Related cytokine | Interleukin-12 (IL-12), a heterodimer of p35 and p40 subunits |
| Receptor components | IL-12Rβ1 and IL-12Rβ2, which bind p40 and p35 respectively |
| Downstream signaling | Jak2-STAT4 pathway activation |
What Is GO:0042163?
Interleukin-12 beta subunit binding (GO:0042163) is a molecular function defined as the binding to the beta subunit of interleukin-12. The beta subunit, also known as IL-12p40, is a component of the heterodimeric cytokines IL-12 and IL-23. This binding event is a key step in the interaction between IL-12 and its receptor, facilitating the formation of a functional receptor complex and subsequent signal transduction.
Why Is interleukin-12 beta subunit binding Important in Cell Biology?
Interleukin-12 beta subunit binding is a critical molecular event in the immune response, as it governs the assembly of the IL-12 receptor complex and the initiation of signaling pathways that lead to T helper 1 (Th1) cell differentiation and interferon-gamma production [5,6]. Dysregulation of this binding can lead to impaired immunity or excessive inflammation, contributing to autoimmune diseases, chronic inflammatory conditions, and cancer [2,3].
• Essential for IL-12 receptor assembly and signaling.
• Regulates Th1 immune responses and cell-mediated immunity.
• Involved in the pathogenesis of autoimmune diseases such as psoriasis and inflammatory bowel disease.
• Plays a role in cancer immunosurveillance and immunotherapy.
• IL-12p40 homodimers act as antagonists, modulating IL-12 activity.
• Target for therapeutic intervention in inflammatory diseases.
• Key for understanding cytokine-receptor interactions.
• Relevant to vaccine adjuvant development.
• Implicated in graft-versus-host disease and transplant rejection.
• Provides insights into Jak-STAT signaling mechanisms.
What Happens During interleukin-12 beta subunit binding?
IL-12 Heterodimer Formation and Secretion
In simple terms: IL-12 is made of two parts, p35 and p40, which combine to form the active cytokine.
IL-12 is a heterodimeric cytokine composed of a p35 alpha subunit and a p40 beta subunit. The p40 subunit is shared with IL-23 and is essential for the stability and secretion of the heterodimer. Upon immune stimulation, such as by pathogens, antigen-presenting cells produce and secrete IL-12, which then acts on target cells like T cells and NK cells.
Binding to the IL-12 Receptor Beta Subunit
In simple terms: The p40 part of IL-12 binds to a specific receptor subunit on the surface of target cells.
The beta subunit of IL-12 (p40) binds to the IL-12 receptor beta 1 (IL-12Rβ1) subunit on the surface of responsive cells. This binding is a prerequisite for the recruitment of the second receptor subunit, IL-12Rβ2, which binds to the p35 subunit, forming a functional receptor complex. The interaction between p40 and IL-12Rβ1 is a key event in the initiation of IL-12 signaling.
Receptor Complex Assembly and Signaling
In simple terms: Once both receptor parts are engaged, they trigger a signal inside the cell.
The functional IL-12 receptor complex is composed of two beta-type cytokine receptor subunits, IL-12Rβ1 and IL-12Rβ2. The binding of IL-12 to these subunits leads to the activation of receptor-associated Janus kinases (Jaks), particularly Jak2 and Tyk2. Jak2 associates with the cytoplasmic membrane-proximal region of IL-12Rβ2 via its amino-terminus, leading to phosphorylation of STAT4, which then translocates to the nucleus to induce gene expression.
Antagonism by IL-12p40 Homodimers
In simple terms: The p40 subunit can also form dimers that block IL-12 activity.
Mouse IL-12 p40 homodimers act as potent antagonists of IL-12. They compete with the IL-12 heterodimer for binding to the IL-12 receptor, thereby inhibiting IL-12-induced responses such as interferon-gamma production and Th1 differentiation. This antagonistic property highlights the regulatory complexity of IL-12 beta subunit binding.
Key Genes Involved in GO:0042163 interleukin-12 beta subunit binding
The following genes and proteins are directly involved in interleukin-12 beta subunit binding and its downstream effects.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL12B | Encodes the p40 beta subunit of IL-12 and IL-23 | Target for anti-inflammatory therapies; polymorphisms linked to autoimmune diseases |
| IL12A | Encodes the p35 alpha subunit of IL-12 | Forms heterodimer with p40; essential for IL-12 activity |
| IL12RB1 | Encodes the beta 1 subunit of the IL-12 receptor | Binds p40; mutations cause immunodeficiency |
| IL12RB2 | Encodes the beta 2 subunit of the IL-12 receptor | Binds p35; associates with Jak2 for signaling |
| JAK2 | Tyrosine kinase that associates with IL-12Rβ2 | Mediates STAT4 phosphorylation |
| TYK2 | Tyrosine kinase associated with IL-12Rβ1 | Involved in IL-12 signaling |
| STAT4 | Transcription factor activated by IL-12 signaling | Drives Th1 gene expression |
| IL23A | Encodes the p19 subunit of IL-23 | Shares p40 with IL-12; involved in Th17 responses |
| IL18 | Pro-inflammatory cytokine | Synergizes with IL-12 in IFN-gamma induction |
| IL39 | New member of IL-12 family | Regulates immune responses |
| IL12RB1 (grass carp) | Fish ortholog of IL-12Rβ1 | Model for evolutionary studies |
| IL12RB2 (grass carp) | Fish ortholog of IL-12Rβ2 | Model for functional characterization |
| GATA3 | Transcription factor in Th2 cells | Negatively regulates IL-12Rβ2 expression |
| T-bet | Transcription factor in Th1 cells | Induces IL-12Rβ2 expression |
| IFNG | Interferon-gamma | Key effector cytokine induced by IL-12 |
| NOS2 | Inducible nitric oxide synthase | Upregulated by IL-12 in macrophages |
| CXCL10 | Chemokine induced by IL-12 | Recruits Th1 cells |
| IL12B (mouse) | Mouse p40 subunit | Used in knockout models to study IL-12 function |
How Is interleukin-12 beta subunit binding Regulated?
Interleukin-12 beta subunit binding is regulated at multiple levels. The expression of IL-12p40 is controlled by transcription factors such as NF-κB and interferon regulatory factors in response to microbial stimuli. The availability of the IL-12 receptor subunits is also regulated; for example, IL-12Rβ2 expression is induced by T-bet and suppressed by GATA3, thereby modulating responsiveness to IL-12. Additionally, the formation of p40 homodimers can competitively inhibit IL-12 binding to its receptor. Post-translational modifications and soluble forms of the receptor may further influence binding.
interleukin-12 beta subunit binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL12B | Psoriasis, Crohn's disease | IL12B knockout mice; point mutation of p40 binding site |
| IL12RB1 | Mendelian susceptibility to mycobacterial diseases | IL12RB1 knockout cell lines; knock-in of patient mutations |
| IL12RB2 | Asthma, autoimmune thyroiditis | IL12RB2 knockout mice; overexpression of IL12RB2 |
| JAK2 | Myeloproliferative neoplasms | JAK2 V617F knock-in mice; point mutation of Jak2 binding domain |
| STAT4 | Rheumatoid arthritis, lupus | STAT4 knockout mice; overexpression of constitutively active STAT4 |
Autoimmune and Inflammatory Diseases
Dysregulated IL-12 signaling, including altered interleukin-12 beta subunit binding, is associated with autoimmune and inflammatory conditions such as psoriasis, inflammatory bowel disease, and rheumatoid arthritis. Genetic variants in IL12B and IL12RB1 have been linked to susceptibility to these diseases. Targeting the IL-12p40 subunit with monoclonal antibodies (e.g., ustekinumab) has proven effective in treating psoriasis and Crohn's disease, underscoring the therapeutic relevance of this binding event.
Cancer
IL-12 plays a critical role in cancer immunosurveillance by promoting Th1 responses and cytotoxic T cell activity. However, chronic IL-12 signaling can also contribute to tumor-promoting inflammation. Interleukin-12 beta subunit binding is therefore a double-edged sword in cancer biology, and understanding its regulation is important for designing immunotherapies.
Infectious Diseases
IL-12 is essential for host defense against intracellular pathogens. Defects in IL-12 receptor subunits, particularly IL-12Rβ1, lead to Mendelian susceptibility to mycobacterial diseases (MSMD), characterized by severe infections with mycobacteria and Salmonella. These conditions highlight the non-redundant role of interleukin-12 beta subunit binding in protective immunity.
From interleukin-12 beta subunit binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of IL-12p40 binding affect Th1 differentiation? | IL12B knockout mice or cells |
| What is the effect of a point mutation in the IL-12Rβ1 binding interface? | Point-mutation knock-in of IL12RB1 |
| Can a tagged IL-12p40 be used to track receptor binding? | Tagged knock-in of IL12B (e.g., HA or GFP) |
| Does overexpression of IL-12Rβ2 enhance IL-12 responsiveness? | Overexpression of IL12RB2 in cell lines |
| What genes are regulated by IL-12 beta subunit binding? | CRISPR library screening with IL-12 stimulation |
| How does IL-12p40 homodimer antagonism work in vivo? | Transgenic overexpression of IL12B homodimer |
How to Study the interleukin-12 beta subunit binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance (SPR) | Binding affinity and kinetics | Measuring IL-12p40-IL-12Rβ1 interaction |
| Co-immunoprecipitation | Protein-protein interactions | Detecting receptor complex assembly |
| Western blot | Protein phosphorylation and expression | Assessing Jak2/STAT4 activation |
| ELISA | Cytokine production | Quantifying IFN-gamma in T cell cultures |
| Flow cytometry | Cell surface receptor expression | Measuring IL-12Rβ1/β2 levels |
| RNA-seq | Global gene expression | Identifying IL-12-induced transcriptional programs |
| CRISPR knockout | Gene function | Disrupting IL12B or IL12RB1 to study binding |
| CRISPR library screening | High-throughput gene function | Discovering novel regulators of IL-12 signaling |
Binding Assays
Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) can measure the binding affinity between IL-12p40 and its receptor subunits. Co-immunoprecipitation and pull-down assays are used to detect physical interactions in cell lysates.
Signaling Pathway Analysis
Phosphorylation of Jak2 and STAT4 can be assessed by Western blotting and immunoprecipitation. Luciferase reporter assays driven by STAT4-responsive promoters can quantify transcriptional activation downstream of interleukin-12 beta subunit binding.
Functional Immune Assays
T cell differentiation assays measure IFN-gamma production by ELISA or ELISPOT. Macrophage activation can be assessed by nitric oxide production or cytokine profiling. These assays link binding events to cellular outcomes.
Genetic and Genomic Approaches
CRISPR-Cas9 knockout of IL12B, IL12RB1, or IL12RB2 in cell lines or primary cells can reveal loss-of-function phenotypes. RNA-seq and ATAC-seq can identify global transcriptional changes upon IL-12 stimulation. CRISPR library screening can uncover novel regulators of IL-12 beta subunit binding.
How CRISPR Can Be Used to Study GO:0042163 interleukin-12 beta subunit binding
Knockout
CRISPR-Cas9 knockout of IL12B, IL12RB1, or IL12RB2 can completely abolish interleukin-12 beta subunit binding, providing a clean background to study its role in immune responses. Knockout cell lines and mice are valuable for validating drug targets and understanding disease mechanisms.
Point Mutation
Introducing specific point mutations in the binding interface of IL-12p40 or IL-12Rβ1 can fine-tune binding affinity and reveal critical residues. This approach helps dissect the structural requirements for binding and signaling.
Knock-in
Knock-in of tagged versions of IL-12p40 (e.g., HA, FLAG, or GFP) allows for real-time tracking of the protein and its interactions. Knock-in of patient-derived mutations can model human diseases associated with defective IL-12 signaling.
Overexpression
Overexpression of IL-12Rβ2 or constitutively active STAT4 can enhance IL-12 responsiveness and amplify downstream effects. This is useful for studying gain-of-function phenotypes and for screening agonists or antagonists.
How EDITGENE Supports interleukin-12 beta subunit binding Research
Researchers studying interleukin-12 beta subunit binding-related genes often need to determine whether a candidate gene is causally involved in receptor assembly, signaling, or immune cell function. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for interleukin-12 beta subunit binding research.
Frequently Asked Questions About interleukin-12 beta subunit binding
What is interleukin-12 beta subunit binding?
Interleukin-12 beta subunit binding (GO:0042163) is a molecular function defined as binding to the beta subunit (p40) of interleukin-12, a cytokine involved in immune responses.
What genes are involved in interleukin-12 beta subunit binding?
Key genes include IL12B (encoding p40), IL12RB1 and IL12RB2 (receptor subunits), JAK2, TYK2, and STAT4 [5,8].
What is the role of IL-12p40 in the immune system?
IL-12p40 is the beta subunit of IL-12 and IL-23; it binds to IL-12Rβ1 and is essential for receptor assembly and Th1 responses [5,6].
How does IL-12 beta subunit binding lead to signaling?
Binding of IL-12p40 to IL-12Rβ1 recruits IL-12Rβ2, which associates with Jak2, leading to STAT4 phosphorylation and gene expression.
What diseases are associated with defects in IL-12 beta subunit binding?
Defects can cause Mendelian susceptibility to mycobacterial diseases, while dysregulation is linked to autoimmune diseases and cancer [2,5].
Can IL-12p40 homodimers inhibit IL-12 signaling?
Yes, IL-12p40 homodimers act as antagonists by competing with IL-12 for receptor binding.
What experimental models are used to study interleukin-12 beta subunit binding?
Common models include IL12B knockout mice, IL12RB1/2 knockout cell lines, and knock-in mice expressing tagged or mutant receptors [2,5].
How can CRISPR be used to study interleukin-12 beta subunit binding?
CRISPR can create knockouts, point mutations, knock-ins, and overexpression models to dissect the function of IL-12p40 and its receptor.
What is the clinical significance of IL-12 beta subunit binding?
It is a target for biologic therapies (e.g., ustekinumab) in psoriasis and Crohn's disease, and is relevant for vaccine development.
Where can I find more information about GO:0042163?
The QuickGO database provides the official definition and annotations for GO:0042163, and PubMed offers extensive literature on IL-12 biology.
Conclusion
Interleukin-12 beta subunit binding (GO:0042163) is a fundamental molecular event that governs IL-12 receptor assembly and downstream signaling, with critical implications for immune regulation, autoimmune diseases, and cancer. Understanding the structural and functional details of this binding event can inform the development of targeted therapies and immunomodulatory strategies. EDITGENE's CRISPR services provide powerful tools to investigate this process and accelerate discoveries in immunology and medicine.
References
- 1. Dinarello CA. 1999. Interleukin-18.. Methods 19(1):121-32 PMID: 10525448
- 2. de Lima JD et al.. 2023. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.. Immunol Invest 52(3):364-397 PMID: 36745138
- 3. Lu Z et al.. 2020. Interleukin 39: a new member of interleukin 12 family.. Cent Eur J Immunol 45(2):214-217 PMID: 33456334
- 4. Qiu X et al.. 2022. Identification and functional characterization of interleukin-12 receptor beta 1 and 2 in grass carp (Ctenopharyngodon idella).. Mol Immunol 143:58-67 PMID: 35042118
- 5. Presky DH et al.. 1996. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits.. Proc Natl Acad Sci U S A 93(24):14002-7 PMID: 8943050
- 6. Wu CY et al.. 1996. Biological function and distribution of human interleukin-12 receptor beta chain.. Eur J Immunol 26(2):345-50 PMID: 8617302
- 7. Gillessen S et al.. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist.. Eur J Immunol 25(1):200-6 PMID: 7843232
- 8. Yamamoto K et al.. 1999. Physical interaction between interleukin-12 receptor beta 2 subunit and Jak2 tyrosine kinase: Jak2 associates with cytoplasmic membrane-proximal region of interleukin-12 receptor beta 2 via amino-terminus.. Biochem Biophys Res Commun 257(2):400-4 PMID: 10198225
